Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Milestone Pharmaceuticals (MIST) has provided an update.
During the 2024 Annual Meeting of Shareholders, the company’s shareholders elected new directors and approved PricewaterhouseCoopers LLP as the auditor for the next year. The elected directors include Joseph Oliveto, Lisa M. Giles, and others, with significant support, while Robert J. Wills had a notable number of votes withheld. Post-meeting, committee reassignments were made, including Stuart M. Duty joining the Nominating and Corporate Governance Committee. Additionally, the company publicly announced Mr. Papa’s appointment to the Board on September 4, 2024.
See more data about MIST stock on TipRanks’ Stock Analysis page.
